Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
US |
|
D
|
Dakota Gold Corp
AMEX:DC
|
US |
Wall St Price Targets
RIGL Price Targets Summary
Rigel Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RIGL is 55.28 USD with a low forecast of 40.4 USD and a high forecast of 85.05 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RIGL's stock price target?
Price Target
55.28
USD
According to Wall Street analysts, the average 1-year price target for RIGL is 55.28 USD with a low forecast of 40.4 USD and a high forecast of 85.05 USD.
What is the Revenue forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 45%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
13%
The compound annual growth rate for Gross Profit over the next 3 years is 13%.
What is the Operating Income forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
3%
The compound annual growth rate for Operating Income over the next 8 years is 3%.
What is the Pre-Tax Income forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
-6%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -6%.
What is the Net Income forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
-6%
The compound annual growth rate for Net Income over the next 8 years is -6%.
